Hydroxysafflor Yellow A-Induced Osteoblast Differentiation and Proliferation of BM-MSCs by Up-Regulating Nuclear Vitamin D Receptor

• Published in: Current molecular medicine Vol. 23; no. 5; p. 410
• Main Authors: Pan, Jiewen, Bao, Youwei, Pan, Shuqing, Zhuang, Danyan, Xu, Yanan, Pan, Xiaoli, Li, Haibo
• Format: Journal Article
• Language: English
• Published: Netherlands 01.01.2023
• Subjects: Bone Marrow Cells - cytology; Bone Marrow Cells - drug effects; Bone Regeneration - drug effects; Calcium - metabolism; Cell Differentiation - drug effects; Cell Proliferation - drug effects; Chalcone - analogs & derivatives; Chalcone - pharmacology; Humans; Mesenchymal Stem Cells - cytology; Mesenchymal Stem Cells - drug effects; Osteoblasts - cytology; Osteoporosis - drug therapy; Quinones - pharmacology; Receptors, Calcitriol - metabolism; HSYA; osteoblast; proliferation; VDR; BM-MSCs; calcium deposition
• ISSN: 1875-5666
• DOI: 10.2174/1566524023666220820125924

Vitamin D receptor (VDR) is critical for mineral and bone homeostasis since it plays an essential role in the osteoblast differentiation of bone marrow mesenchymal stem cells (BM-MSCs). Hydroxysafflor yellow A (HSYA) has the potential to promote bone mineralization and inhibit bone resorption, while its detailed mechanism needs to be elaborated. This study intends to explore the action of HSYA on the proliferation and differentiation of BM-MSC and the underlying mechanism. Different concentrations of HSYA to BM-MSC and CCK-8, and EdU were used to detect cell viability and proliferation. The alkaline phosphatase (ALP) was used to observe the differentiation ability of BM-MSC osteoblasts. The calcium uptake and mineralization of osteoblast-like cells were observed by alizarin red staining. The level of calcium ion uptake in cells was detected by flow cytometry. AutoDock was performed for molecular docking of HSYA to VDR protein. Immunofluorescence and western blotting were performed to detect the expression of VDR expression levels. Finally, the effect of VDR was verified by a VDR inhibitor. After treatment with HSYA, the proliferation and calcium uptake of BM-MSC were increased. The level of ALP increased significantly and reached its peak on the 12th day. HSYA promoted calcium uptake and calcium deposition, and mineralization of osteoblasts. The western blotting and immunofluorescence showed that HSYA increased the expression of VDR in the osteoblast-like cell's nucleus and upregulated Osteocalcin, S100 calcium-binding protein G, and CYP24A1. In addition, HYSA treatment increased the expression of osteopontin and the synthesis of osteogenic proteins, such as Type 1 collagen. After the addition of the VDR inhibitor, the effect of HSYA was weakened. HSYA could significantly promote the activity and proliferation of osteoblasts and increase the expression level of VDR in osteoblasts. HSYA may also improve calcium absorption by osteoblasts by regulating the synthesis of calciumbinding protein and vitamin D metabolic pathway-related proteins.